Unraveling the role of the ACKR3/CXCR7 receptor in glioblastoma cells survival and invasion in the tumor relapse.

Project Details

AcronymEXOKINE (ACKR3/CXCR7)
StatusFinished
Effective start/end date1/07/2130/11/23

Funding

  • FNRS - Fonds National de la Recherche Scientifique: €250,000.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.